Alamy logo

Barry dolling Stock Photos and Images

(20)See barry dolling stock video clips

Barry dolling Stock Photos and Images

Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April, is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton, Surrey. Stock Photo
RMPPDFK7–Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April, is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton, Surrey.
Embargoed to 1700 Monday September 24 Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018 is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWND–Embargoed to 1700 Monday September 24 Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018 is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Radiographers Trina Herbert (left), and Gillian Smith help patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy. Stock Photo
RMPPB1MY–Radiographers Trina Herbert (left), and Gillian Smith help patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy.
Radiographers Trina Herbert (left), and Gillian Smith help patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy. Stock Photo
RMPPAWK2–Radiographers Trina Herbert (left), and Gillian Smith help patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy.
Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, after treating patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWMT–Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, after treating patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Radiographer Gillian Smith helps patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy. Stock Photo
RMPPAWJ8–Embargoed to 1700 Monday September 24 Radiographer Gillian Smith helps patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy.
Professor Uwe Oelfke, Head of the Joint Department of Physics of The Royal Marsden and the Institute of Cancer Research (ICR), after treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPB1KP–Professor Uwe Oelfke, Head of the Joint Department of Physics of The Royal Marsden and the Institute of Cancer Research (ICR), after treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April, is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton, Surrey. Stock Photo
RMPPDFH2–Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April, is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton, Surrey.
Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April, prepares for treatment at the Royal Marsden Hospital in Sutton, Surrey. He is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine. Stock Photo
RMPPDFGB–Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April, prepares for treatment at the Royal Marsden Hospital in Sutton, Surrey. He is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine.
Embargoed to 1700 Monday September 24 Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018 is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWN1–Embargoed to 1700 Monday September 24 Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018 is the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, prepares for treatment after becoming the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWN6–Embargoed to 1700 Monday September 24 Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, prepares for treatment after becoming the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, after treating patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPB1M1–Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, after treating patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, treats patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPB1ME–Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, treats patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Members of the PRISM clinical trial team monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWHP–Embargoed to 1700 Monday September 24 Members of the PRISM clinical trial team monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 A radiation warning sign during the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWNN–Embargoed to 1700 Monday September 24 A radiation warning sign during the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Gillian Smith, MR Linac Radiographer, monitors the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWJE–Embargoed to 1700 Monday September 24 Gillian Smith, MR Linac Radiographer, monitors the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Radiographers Trina Herbert (left), and Gillian Smith help patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy. Stock Photo
RMPPAWM2–Embargoed to 1700 Monday September 24 Radiographers Trina Herbert (left), and Gillian Smith help patient Barry Dolling, aged 65, from Selsdon, Surrey, after treatment using a Magnetic Resonance Linear Accelerator (MR Linac) machine, at the Royal Marsden Hospital in Sutton Surrey. Dolling was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy.
(L-R) Physicist Adam Mitchell, Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, and Trina Herbert, MR Linac Lead Radiographer, monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPB1K3–(L-R) Physicist Adam Mitchell, Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden, and Trina Herbert, MR Linac Lead Radiographer, monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Dr Alison Tree (right), Consultant Clinical Oncologist at The Royal Marsden, and her fellow team members of the PRISM clinical trial monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWMG–Embargoed to 1700 Monday September 24 Dr Alison Tree (right), Consultant Clinical Oncologist at The Royal Marsden, and her fellow team members of the PRISM clinical trial monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Embargoed to 1700 Monday September 24 Dr Alison Tree (3rd from bottom), Consultant Clinical Oncologist at The Royal Marsden, and her fellow team members of the PRISM clinical trial monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey. Stock Photo
RMPPAWK6–Embargoed to 1700 Monday September 24 Dr Alison Tree (3rd from bottom), Consultant Clinical Oncologist at The Royal Marsden, and her fellow team members of the PRISM clinical trial monitor the treatment of patient Barry Dolling, aged 65, from Selsdon, Surrey, who was diagnosed with prostate cancer in April 2018, and became the first patient in the UK to receive a pioneering new form of radiotherapy - using a Magnetic Resonance Linear Accelerator (MR Linac) machine - at the Royal Marsden Hospital in Sutton Surrey.
Page 1 of 1